Topic: mobile medical apps
The collaborators see the combination of their technologies facilitating remote care of people with diabetes and better management of the condition.
Novartis is taking a digital approach to clinical trials to track the progression of ophthalmic disease through its new FocalView app.
Trayt released a mobile application designed to help diagnose, track and treat patients with autism, ADHD and other neurodevelopmental disorders.
A study using Mindstrong Health’s app that analyzes smartphone habits showed promise in predicting when and why mental health issues occur.
Drayson hoped to show the app improved outcomes by enabling better self-management but the data fell short in some key areas.
Janssen has developed a mobile toolkit for trial supply management and patient engagement that can track adherence to each pill.
Greenphire integrates its patient payment solution into mProve's patient engagement mobile app.
GlaxoSmithKline and Propeller Health are expanding their R&D partnership, inked in 2015, into a commercial one.
MannKind and One Drop are launching a study to gauge whether pairing the former's inhaled insulin with the latter's digital diabetes care platform will improve outcomes.
The FDA rolled out its Digital Health Innovation Action Plan, which includes a program aimed at accelerating approval for digital health technology.